home / stock / fwbi / fwbi news

FWBI News and Press, First Wave BioPharma Inc. From 09/14/23

Stock Information
Company Name: First Wave BioPharma Inc.
Stock Symbol: FWBI
Market: NASDAQ
Menu
FWBI FWBI Quote FWBI Short FWBI News FWBI Articles FWBI Message Board
Get FWBI Alerts

News, Short Squeeze, Breakout and More Instantly...
FWBI - First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi

BOCA RATON, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) dis...
FWBI - Common Penny Stocks Trading Obstacles

2023-09-06 06:05:00 ET 3 Common Trading Obstacles for Buying and Selling Penny Stocks Penny stocks, often regarded as the hidden gems of the stock market, present a unique opportunity for investors. These stocks, typically priced below $5, offer the potential for significant returns. Ho...

FWBI - First Wave BioPharma to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

BOCA RATON, Fla., Sept. 05, 2023 (GLOBE NEWSWIRE) --  First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastroint...

FWBI - First Wave BioPharma prices ~$2.1M public offering of shares, warrants

2023-07-19 08:33:31 ET Biopharmaceutical company First Wave BioPharma ( NASDAQ: FWBI ) said on Wednesday that it has priced an ~$2.1M public offering of shares and warrants. The issuance involves 3.3M shares and warrants to purchase up to 6.6M shares at $0.64 per share and ass...
FWBI - First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering

BOCA RATON, Fla., July 19, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointes...

FWBI - RMTI, CYRX and TMC among pre-market losers

2023-07-14 08:15:40 ET First Wave BioPharma ( FWBI ) -32% . Healthcare Triangle ( HCTI ) -31% . SunCar Technology Group ( SDA ) -30% . Rockwell Medical ( RMTI ) -30% . Cadrenal Therapeutics ( CVKD ) -30% . Viasat ( VSAT ) -...

FWBI - Applied DNA, 60 Degrees top healthcare gainers; First Wave, Cadrenal among losers

2023-07-13 10:09:11 ET Gainers: Applied DNA Sciences ( APDN ) +29% . 60 Degrees Pharmaceuticals ( SXTP ) +21% .  Exicure ( XCUR ) +13% . Psychemedics ( PMD ) +11% . Plus Therapeutics ( PSTV ) +9% . Losers: First W...
FWBI - TGTX, HIMS and CEI among pre-market losers

2023-07-13 08:30:54 ET Ault Alliance ( AULT ) -35% announces a second partial distribution of TOG securities of approximately $0.37 for each share of ault alliance common stock. First Wave BioPharma ( FWBI ) -34% after Phase 2 setback for gut therapy. Cryop...

FWBI - First Wave BioPharma Announces Initial Topline Results from Phase 2 SPAN Clinical Trial Investigating Enhanced Adrulipase Formulation

BOCA RATON, Fla., July 13, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal...

FWBI - First Wave BioPharma Announces Final Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation

BOCA RATON, Fla., June 28, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointesti...
Previous 10 Next 10